Evergrande Health (00708) said its profit attributable to owners for the six months ended 30 June 2017 surged 602% year-on-year to HK$83.87 million, because of the incremental profit from health and living projects in the reporting period.
Basic and diluted earnings per share were HK0.971 cents.
Revenue amounted to HK$576 million, an increase of 215% from a year earlier.
The gross profit margin increased from 25% for the six months ended 2016 to 54% for the reporting period.
No interim dividend will be distributed.
【母親節限時優惠】 送價值$288維柏健30天逆轉肌齡(膠原蛋白+生物素) ► 火速行動
